Skip to main content
. 2016 Apr 15;8(4):1848–1856.

Figure 2.

Figure 2

miR-296-3p increases drug sensitivity to 5-FU, DDP and paclitaxel lung cancer cells. A, B. CCK8 assay was used to analyze cell survival of A549 cells. The cells were transfected with miR-296-3p mimics or anti-miR-296-3p transfection and then exposed to DDP and paclitaxel for 3 days. C, D. CCK8 assay was used to analyze cell survival of H157 cells. The cells were transfected with miR-296-3p mimics or anti-miR-296-3p transfection and then exposed to DDP and paclitaxel for 3 days.